-
Product Insights
Polyomavirus Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Polyomavirus Infections - Drugs In Development, 2023’, provides an overview of the Polyomavirus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Polyomavirus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Cytomegalovirus (HHV-5) Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Cytomegalovirus (HHV-5) Infections - Drugs In Development, 2023’, provides an overview of the Cytomegalovirus (HHV-5) Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cytomegalovirus (HHV-5) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MTX-005 in Polyomavirus Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MTX-005 in Polyomavirus Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.MTX-005 in Polyomavirus InfectionsDrug Details:MTX-005 is under development for the treatment of BK...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BI-770371 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BI-770371 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.BI-770371 in Solid Tumor Drug Details:BI-770371 is under development for the treatment of...
-
Product Insights
Cardiac Valve Repair – Corcym UK Ltd – MEMO 3D
GlobalData, the industry analysis specialist, has released its latest report: Cardiac Valve Repair - Corcym UK Ltd - MEMO 3D. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted...
-
Product Insights
Cardiac Valve Repair – Corcym UK Ltd – MEMO 4D
GlobalData, the industry analysis specialist, has released its latest report: Cardiac Valve Repair - Corcym UK Ltd - MEMO 4D. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted...
-
Product Insights
Cardiac Valve Repair – Corcym UK Ltd – MEMO 3D RECHORD
GlobalData, the industry analysis specialist, has released its latest report: Cardiac Valve Repair - Corcym UK Ltd - MEMO 3D RECHORD. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also...
-
Company Profile
NewnCino Inc – Company Profile
nCino Inc (nCino) offers a bank operating system, a cloud-based solution that resolves banking opportunities and challenges. The company leverages the flexibility, security and scalability of the salesforce platform and delivers an end-to-end banking solution. It integrates the bank’s accounting system, enterprise content management, data analytics, loan origination and customer relationship management. nCino also offers a commercial loan origination system, document manager, loan auto decision, treasury management onboarding, customer portal, reports and dashboard, credit analysis and memo, collateral management, risk...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – MTX-005
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry MTX-005 Drug Details MTX-005 is under development for the treatment of BK virus infection...
-
Product Insights
Cytomegalovirus (HHV-5) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Cytomegalovirus (CMV or HHV-5) is a contagious infection caused by a member of the herpes virus family. CMV is spread through saliva or urine. The symptoms of CMV include fever, pneumonia, weight loss, hearing, neurological and developmental problems. Exposure to direct contact with an infected surface or organism, weakened immune system and congenital factors are some predisposing factors of HHV-5. The CMV pipeline drugs market research report provides comprehensive information on the therapeutics under development for CMV, complete with analysis...